# Treatment of Neonatal Abstinence Syndrome

> **NCT01723722** · PHASE4 · COMPLETED · sponsor: **Eastern Maine Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Neonatal Abstinence Syndrome

## Interventions

- **DRUG:** Methadone
- **DRUG:** Diluted Deodorized Tincture of Opium

## Key facts

- **NCT ID:** NCT01723722
- **Lead sponsor:** Eastern Maine Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01723722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01723722, "Treatment of Neonatal Abstinence Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01723722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*